D Wang1, J M Taboas, R S Tuan. 1. Cartilage Biology and Orthopaedics Branch, National Institute of Arthritis, and Musculoskeletal and Skin Diseases, National Institutes of Health, Department of Health and Human Services Bethesda, MD 20892, USA.
Abstract
OBJECTIVE: Cell-based tissue engineering strategies are currently in clinical use and continue to be developed at a rapid pace for the repair of cartilage defects. Regardless of the repair methodology, chondrocytes within newly regenerated cartilage remain susceptible to the abnormal inflammatory and mechanical environments that underlie osteoarthritic disease, likely compromising the implant's integration, function, and longevity. The present study investigates the use of parathyroid hormone-related peptide (PTHrP) overexpression for chondroprotection. DESIGN: Bovine articular chondrocytes were transfected with human PTHrP (hPTHrP) constructs (1-141 or 1-173) and subjected to injurious cyclic tensile strain (CTS; 0.5 Hz and 16% elongation) for 48 h. mRNA expression of matrix remodeling, inflammatory signaling, hypertrophic, and apoptotic genes were examined with real-time reverse transcription polymerase chain reaction. Nitric oxide (NO) and prostaglandin E₂ (PGE₂) production were measured using the Griess assay and enzyme immunoassay (EIA), respectively. RESULTS: CTS-induced an arthritic phenotype in articular chondrocytes as indicated by increased gene expression of collagenases and aggrecanases and increased production of NO and PGE₂. Additionally, CTS increased collagen type X (Col10a1) mRNA expression, whereas overexpression of either hPTHrP isoform inhibited CTS-induced Col10a1 gene expression. However, hPTHrP 1-141 augmented CTS-induced NO and PGE₂ production, and neither hPTHrP isoform had any significant effect on apoptotic genes. CONCLUSIONS: Our results suggest that chondrocytes overexpressing PTHrP resist mechanical strain-induced hypertrophic-like changes. Therapeutic PTHrP gene transfer may be considered for chondroprotection applications in newly regenerated cartilage.
OBJECTIVE: Cell-based tissue engineering strategies are currently in clinical use and continue to be developed at a rapid pace for the repair of cartilage defects. Regardless of the repair methodology, chondrocytes within newly regenerated cartilage remain susceptible to the abnormal inflammatory and mechanical environments that underlie osteoarthritic disease, likely compromising the implant's integration, function, and longevity. The present study investigates the use of parathyroid hormone-related peptide (PTHrP) overexpression for chondroprotection. DESIGN:Bovine articular chondrocytes were transfected with humanPTHrP (hPTHrP) constructs (1-141 or 1-173) and subjected to injurious cyclic tensile strain (CTS; 0.5 Hz and 16% elongation) for 48 h. mRNA expression of matrix remodeling, inflammatory signaling, hypertrophic, and apoptotic genes were examined with real-time reverse transcription polymerase chain reaction. Nitric oxide (NO) and prostaglandin E₂ (PGE₂) production were measured using the Griess assay and enzyme immunoassay (EIA), respectively. RESULTS:CTS-induced an arthritic phenotype in articular chondrocytes as indicated by increased gene expression of collagenases and aggrecanases and increased production of NO and PGE₂. Additionally, CTS increased collagen type X (Col10a1) mRNA expression, whereas overexpression of either hPTHrP isoform inhibited CTS-induced Col10a1 gene expression. However, hPTHrP 1-141 augmented CTS-induced NO and PGE₂ production, and neither hPTHrP isoform had any significant effect on apoptotic genes. CONCLUSIONS: Our results suggest that chondrocytes overexpressing PTHrP resist mechanical strain-induced hypertrophic-like changes. Therapeutic PTHrP gene transfer may be considered for chondroprotection applications in newly regenerated cartilage.
Authors: T H Vu; J M Shipley; G Bergers; J E Berger; J A Helms; D Hanahan; S D Shapiro; R M Senior; Z Werb Journal: Cell Date: 1998-05-01 Impact factor: 41.582
Authors: Xibin Wang; Paul A Manner; Alan Horner; Lillian Shum; Rocky S Tuan; Glen H Nuckolls Journal: Osteoarthritis Cartilage Date: 2004-12 Impact factor: 6.576
Authors: Thomas Aigner; Katrin Fundel; Joachim Saas; Pia M Gebhard; Jochen Haag; Tilo Weiss; Alexander Zien; Franz Obermayr; Ralf Zimmer; Eckart Bartnik Journal: Arthritis Rheum Date: 2006-11
Authors: Haneen A Abusharkh; Alia H Mallah; Mahmoud M Amr; Juana Mendenhall; Bulent A Gozen; Edwin M Tingstad; Nehal I Abu-Lail; Bernard J Van Wie Journal: In Vitro Cell Dev Biol Anim Date: 2021-06-15 Impact factor: 2.723
Authors: Frances C Bach; Kirsten Rutten; Kristyanne Hendriks; Frank M Riemers; Peter Cornelissen; Alain de Bruin; Ger J Arkesteijn; Richard Wubbolts; William A Horton; Louis C Penning; Marianna A Tryfonidou Journal: J Cell Physiol Date: 2014-12 Impact factor: 6.384
Authors: Clara Sanjurjo-Rodríguez; Rocío Castro-Viñuelas; Tamara Hermida-Gómez; Isaac Manuel Fuentes-Boquete; Francisco Javier de Toro; Francisco Javier Blanco; Silvia María Díaz-Prado Journal: Int J Med Sci Date: 2017-09-28 Impact factor: 3.738